Home » Topics » Regulatory

Regulatory
RSS

Canadian approval obtained for Serostim

Dec. 4, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

FDA approves Verelan PM; launch scheduled for early 1999

Dec. 4, 1998

Genzyme General receives FDA approval for Thyrogen

Dec. 3, 1998

U.K. approval for new controlled-release nifedipine based on TIMERx technology

Dec. 2, 1998

FDA approves new indications, dosing regimens for Vantin

Dec. 2, 1998

Diane-35 now available in Canada for treatment of acne

Dec. 2, 1998

Unimed receives U.S. patent protection for dronabinol in treatment of dementia

Nov. 30, 1998

SSRI promising in the treatment of children and adolescents with OCD

Nov. 30, 1998

International study focuses on riluzole as a new approach to treating PD

Nov. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...